A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy - A preliminary report Meeting Abstract


Authors: Adusumilli, P. S.; Zauderer, M.; Rusch, V.; O'Cearbhaill, R.; Ngai, D.; Chintala, N.; Halton, E.; Diamonte, C.; Modi, S.; Solomon, S.; Brentjens, R.; Riviere, I.; Sadelain, M.
Abstract Title: A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy - A preliminary report
Meeting Title: 21st Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Journal Title: Molecular Therapy
Volume: 26
Issue: 5 Suppl. 1
Meeting Dates: 2018 May 16-19
Meeting Location: Chicago, IL
ISSN: 1525-0016
Publisher: Nature Publishing Group  
Date Published: 2018-05-01
Start Page: 158
End Page: 159
Language: English
ACCESSION: WOS:000435342202012
PROVIDER: wos
DOI: 10.1016/j.ymthe.2018.05.001
Notes: Meeting Abstract: 342 -- Source: Wos
Altmetric Score
MSK Authors
  1. Valerie W Rusch
    651 Rusch
  2. Renier J Brentjens
    189 Brentjens
  3. Shanu Modi
    132 Modi
  4. Elizabeth F Halton
    18 Halton
  5. Stephen Solomon
    266 Solomon
  6. Michel W J Sadelain
    452 Sadelain
  7. Isabelle C Riviere
    161 Riviere
  8. Daniel Ngai
    3 Ngai